Literature DB >> 26124220

Effect of Alendronate on Bone Formation during Tooth Extraction Wound Healing.

R Tanoue1, K Koi2, J Yamashita3.   

Abstract

Alendronate (ALN) is an antiresorptive agent widely used for the treatment of osteoporosis. Its suppressive effect on osteoclasts has been extensively studied. However, the effect of ALN on bone formation is not as clear as its effect on resorption. The objective was to determine the effect of short-term ALN on bone formation and tooth extraction wound healing. Molar tooth extractions were performed in mice. ALN, parathyroid hormone (PTH), or saline (vehicle control) was administered. PTH was used as the bone anabolic control. Mice were euthanized at 3, 5, 7, 10, and 21 d after extractions. Hard tissue healing was determined histomorphometrically. Neutrophils and lymphatic and blood vessels were quantified to evaluate soft tissue healing. Gene expression in the wounds was assessed at the RNA level. Furthermore, the vossicle bone transplant system was used to verify findings from extraction wound analysis. Alkaline phosphatase (ALP) was visualized in the vossicles to assess osteoblast activity. ALN exhibited no negative effect on bone formation. In intact tibiae, ALN increased bone mass significantly more than PTH did. Consistently, significantly elevated osteoblast numbers were noted. In the extraction sockets, bone fill in the ALN-treated mice was equivalent to the control. Genes associated with bone morphogenetic protein signaling, such as bmp2, nog, and dlx5, were activated in the extraction wounds of the ALN-treated animals. Bone formation in vossicles was significantly enhanced in the ALN versus PTH group. In agreement with this, ALN upregulated ALP activity considerably in vossicles. Neutrophil aggregation and suppressed lymphangiogenesis were evident in the soft tissue at 21 d after extraction, although gross healing of extraction wounds was uneventful. Bone formation was not impeded by short-term ALN treatment. Rather, short-term ALN treatment enhanced bone formation. ALN did not alter bone fill in extraction sockets. © International & American Associations for Dental Research 2015.

Entities:  

Keywords:  diphosphonates; inflammation; lymphatic vessels; neutrophils; osteoblasts; osteoclasts

Mesh:

Substances:

Year:  2015        PMID: 26124220      PMCID: PMC4547318          DOI: 10.1177/0022034515592867

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  28 in total

1.  Bisphosphonate-induced osteonecrosis of the jaw in a rat model arises first after the bone has become exposed. No primary necrosis in unexposed bone.

Authors:  Jahan Abtahi; Fredrik Agholme; Olof Sandberg; Per Aspenberg
Journal:  J Oral Pathol Med       Date:  2012-01-23       Impact factor: 4.253

2.  The influence of alendronate on the healing of extraction sockets of ovariectomized rats assessed by in vivo micro-computed tomography.

Authors:  Jeong-Hyun Jee; Wan Lee; Byung Do Lee
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-06-29

3.  The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration.

Authors:  Chau-Zen Wang; Shih-Mao Chen; Chung-Hwan Chen; Chih-Kuang Wang; Gwo-Jaw Wang; Je-Ken Chang; Mei-Ling Ho
Journal:  Biomaterials       Date:  2010-08-16       Impact factor: 12.479

4.  Modeling and remodeling of human extraction sockets.

Authors:  Leonardo Trombelli; Roberto Farina; Andrea Marzola; Leopoldo Bozzi; Birgitta Liljenberg; Jan Lindhe
Journal:  J Clin Periodontol       Date:  2008-05-21       Impact factor: 8.728

5.  Ossicle and vossicle implant model systems.

Authors:  Glenda J Pettway; Laurie K McCauley
Journal:  Methods Mol Biol       Date:  2008

6.  Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome.

Authors:  Shankar S Iyer; Wilco P Pulskens; Jeffrey J Sadler; Loes M Butter; Gwendoline J Teske; Tyler K Ulland; Stephanie C Eisenbarth; Sandrine Florquin; Richard A Flavell; Jaklien C Leemans; Fayyaz S Sutterwala
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-16       Impact factor: 11.205

7.  Bilateral fractures of the femur diaphysis in a patient with rheumatoid arthritis on long-term treatment with alendronate: clues to the mechanism of increased bone fragility.

Authors:  Matthijs P Somford; Frits W Draijer; Bregje J W Thomassen; Pascale M Chavassieux; Georges Boivin; Socrates E Papapoulos
Journal:  J Bone Miner Res       Date:  2009-10       Impact factor: 6.741

8.  Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells.

Authors:  Gustavo Duque; Daniel Rivas
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

9.  Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone.

Authors:  Junro Yamashita; Nabanita S Datta; Yong-Hee P Chun; Dong-Ye Yang; Allison A Carey; Jaclynn M Kreider; Steven A Goldstein; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2008-05       Impact factor: 6.741

10.  Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.

Authors:  Aymen I Idris; Javier Rojas; Iain R Greig; Rob J Van't Hof; Stuart H Ralston
Journal:  Calcif Tissue Int       Date:  2008-02-08       Impact factor: 4.333

View more
  11 in total

1.  Clodronate-Loaded Liposome Treatment Has Site-Specific Skeletal Effects.

Authors:  M N Michalski; L E Zweifler; B P Sinder; A J Koh; J Yamashita; H Roca; L K McCauley
Journal:  J Dent Res       Date:  2019-01-09       Impact factor: 6.116

2.  Effects of Condensation on Peri-implant Bone Density and Remodeling.

Authors:  L Wang; Y Wu; K C Perez; S Hyman; J B Brunski; U Tulu; C Bao; B Salmon; J A Helms
Journal:  J Dent Res       Date:  2017-01-03       Impact factor: 6.116

3.  Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.

Authors:  Takahiro Yanagisawa; Masakazu Ishii; Manami Takahashi; Kei Fujishima; Masahiro Nishimura
Journal:  Mol Biol Rep       Date:  2020-09-04       Impact factor: 2.316

4.  Effect of anti-angiogenesis induced by chemotherapeutic monotherapy, chemotherapeutic/bisphosphonate combination therapy and anti-VEGFA mAb therapy on tooth extraction socket healing in mice.

Authors:  Yuri Akita; Shinichiro Kuroshima; Kazunori Nakajima; Hiroki Hayano; Riho Kanai; Muneteru Sasaki; Takashi Sawase
Journal:  J Bone Miner Metab       Date:  2017-10-17       Impact factor: 2.626

Review 5.  Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.

Authors:  Jason T Wan; Douglas M Sheeley; Martha J Somerman; Janice S Lee
Journal:  Bone Res       Date:  2020-03-11       Impact factor: 13.567

6.  Histopathological Examination of the Effects of Local and Systemic Bisphosphonate Usage in Bone Graft Applications on Bone Healing.

Authors:  Sabit Demircan; S Cemil İşler
Journal:  J Maxillofac Oral Surg       Date:  2020-01-27

Review 7.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

8.  Delayed wound healing after tooth extraction and self-reported kyphosis in Japanese men and women.

Authors:  Akira Taguchi; Mikio Kamimura; Yukio Nakamura; Noriyuki Sugino; Akira Ichinose; Hisayoshi Maezumi; Takashi Fukuzawa; Ryouhei Ashizawa; Kenji Takahara; Susumu Gushiken; Keijiro Mukaiyama; Shota Ikegami; Shigeharu Uchiyama; Hiroyuki Kato
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

9.  Effect of 1% sodium alendronate in the non-surgical treatment of periodontal intraosseous defects: a 6-month clinical trial.

Authors:  Bernardo Carvalho Dutra; Alcione Maria Soares Dutra Oliveira; Peterson Antônio Dutra Oliveira; Flavio Ricardo Manzi; Sheila Cavalca Cortelli; Luís Otávio de Miranda Cota; Fernando Oliveira Costa
Journal:  J Appl Oral Sci       Date:  2017 May-Jun       Impact factor: 2.698

Review 10.  Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.

Authors:  Jason T Wan; Douglas M Sheeley; Martha J Somerman; Janice S Lee
Journal:  Bone Res       Date:  2020-03-11       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.